Correlation Between Kancera AB and Klaria Pharma
Can any of the company-specific risk be diversified away by investing in both Kancera AB and Klaria Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kancera AB and Klaria Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kancera AB and Klaria Pharma Holding, you can compare the effects of market volatilities on Kancera AB and Klaria Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kancera AB with a short position of Klaria Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kancera AB and Klaria Pharma.
Diversification Opportunities for Kancera AB and Klaria Pharma
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kancera and Klaria is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Kancera AB and Klaria Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Klaria Pharma Holding and Kancera AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kancera AB are associated (or correlated) with Klaria Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Klaria Pharma Holding has no effect on the direction of Kancera AB i.e., Kancera AB and Klaria Pharma go up and down completely randomly.
Pair Corralation between Kancera AB and Klaria Pharma
Assuming the 90 days trading horizon Kancera AB is expected to under-perform the Klaria Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Kancera AB is 1.39 times less risky than Klaria Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The Klaria Pharma Holding is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 50.00 in Klaria Pharma Holding on September 1, 2024 and sell it today you would lose (5.00) from holding Klaria Pharma Holding or give up 10.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.63% |
| Values | Daily Returns |
Kancera AB vs. Klaria Pharma Holding
Performance |
| Timeline |
| Kancera AB |
| Klaria Pharma Holding |
Kancera AB and Klaria Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kancera AB and Klaria Pharma
The main advantage of trading using opposite Kancera AB and Klaria Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kancera AB position performs unexpectedly, Klaria Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klaria Pharma will offset losses from the drop in Klaria Pharma's long position.| Kancera AB vs. Combigene AB | Kancera AB vs. Cantargia AB | Kancera AB vs. Fingerprint Cards AB | Kancera AB vs. Spectrumone publ AB |
| Klaria Pharma vs. Kancera AB | Klaria Pharma vs. Cyxone AB | Klaria Pharma vs. Lidds AB | Klaria Pharma vs. Cantargia AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |